Abstract
The importance of Alternaria sp. fungi to human health ranges from being etiological agents of serious infections with poor prognosis in immunosuppressed individuals to their association with respiratory allergic diseases. The present work focuses on Alternaria infectoria, as a model organism of the genus, and was designed to unravel melanin production in the response to antifungals. After the characterization of the pigment produced by A. infectoria, we studied the dynamics of dihydroxynaphthalene (DHN)-melanin production during growth, the degree of melanization in response to antifungals, and how melanization affected the susceptibility to several classes of therapeutic drugs. We demonstrate that A. infectoria increased melanin deposition in the cell walls in response to nikkomycin Z, caspofungin and itraconazole but not in response to fluconazole or amphotericin B. These results indicated that A. infectoria activates DHN-melanin synthesis in response to certain fungal drugs, possibly as a protective mechanism against antifungal drugs. Inhibition of DHN-melanin synthesis by pyroquilon resulted in a lower minimum effective concentration (MEC) of caspofungin, with enhanced morphological changes (increased balloon size) characterized by thinner and less organized A. infectoria cell walls. In summary, A. infectoria synthesizes melanin in response to certain antifungal drugs and its susceptibility is influenced by melanization suggesting a therapeutic potential to drug combinations that affect melanin synthesis.

This publication has 64 references indexed in Scilit: